Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2015 Aug 25;5(8):e009021.
doi: 10.1136/bmjopen-2015-009021.

Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil

Alexandre Grangeiro  1 , Márcia Thereza Couto  1 , Maria Fernanda Peres  1 , Olinda Luiz  1 , Eliana Miura Zucchi  2 , Euclides Ayres de Castilho  1 , Denize Lotufo Estevam  3 , Rosa Alencar  3 , Karina Wolffenbüttel  3 , Maria Mercedes Escuder  4 , Gabriela Calazans  5 , Dulce Ferraz  6 , Érico Arruda  7 , Maria da Gloria Corrêa  8 , Fabiana Rezende Amaral  9 , Juliane Cardoso Villela Santos  10 , Vivian Salles Alvarez  1 , Tiago Kietzmann  1
Affiliations
Multicenter Study

Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil

Alexandre Grangeiro et al. BMJ Open. .

Abstract

Introduction: Few results from programmes based on combination prevention methods are available. We propose to analyse the degree of protection provided by postexposure prophylaxis (PEP) for consensual sexual activity at healthcare clinics, its compensatory effects on sexual behaviour; and the effectiveness of combination prevention methods and pre-exposure prophylaxis (PrEP), compared with exclusively using traditional methods.

Methods and analysis: A total of 3200 individuals aged 16 years or older presenting for PEP at 5 sexually transmitted disease (STD)/HIV clinics in 3 regions of Brazil will be allocated to one of two groups: the PEP group-individuals who come to the clinic within 72 h after a sexual exposure and start PEP; and the non-PEP group-individuals who come after 72 h but within 30 days of exposure and do not start PEP. Clinical follow-up will be conducted initially for 6 months and comprise educational interventions based on information and counselling for using prevention methods, including PrEP. In the second study phase, individuals who remain HIV negative will be regrouped according to the reported use of prevention methods and observed for 18 months: only traditional methods; combined methods; and PrEP. Effectiveness will be analysed according to the incidence of HIV, syphilis and hepatitis B and C and protected sexual behaviour. A structured questionnaire will be administered to participants at baseline and every 6 months thereafter. Qualitative methods will be employed to provide a comprehensive understanding of PEP-seeking behaviour, preventive choices and exposure to HIV.

Ethics and dissemination: This study will be conducted in accordance with the resolution of the School of Medicine Research Ethics Commission of Universidade de São Paulo (protocol no. 251/14). The databases will be available for specific studies, after management committee approval. Findings will be presented to researchers, health managers and civil society members by means of newspapers, electronic media and scientific journals and meetings.

Keywords: Brazil; HIV; Post-Exposure Prophylaxis; Pre-Exposure Prophylaxis; combination HIV prevention; prevention and control.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Criteria for postexposure prophylaxis use in Brazil.
Figure 2
Figure 2
Inclusion flow chart (PEP, postexposure prophylaxis).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. The International AIDS Society. The International AIDS Conference, The University of California, San Francisco. The Washington D.C Declaration: turning the tide together: a declaration to end the AIDS epidemic Washington DC: 2012. http://www.2endaids.org/about.html (accessed 14 Apr 2014).
    1. Padian N, McCoy SI, Karim SS et al. . HIV prevention transformed: the new prevention research agenda. Lancet 2011;378:269–78. 10.1016/S0140-6736(11)60877-5 - DOI - PMC - PubMed
    1. Meyer-Rath G, Over M. Investigating the impact of treatment on new HIV infection. PLoS Med 2012;9:1–92.
    1. World Health Organization. The strategic use of antiretroviral: to help end the HIV epidemic. Geneva, 2012.
    1. Grant RM, Lama JR, Anderson PL et al. . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2787–99. 10.1056/NEJMoa1011205 - DOI - PMC - PubMed

Publication types

Substances